Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amphastar Pharmaceuticals Inc (AMPH) vs Johnson & Johnson (JNJ) Price & Performance

Amphastar Pharmaceuticals IncTrade
Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

Amphastar Pharmaceuticals Inc vs Johnson & Johnson — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Johnson & Johnson trades at $258.7 (market cap $626.09B). The key difference: Johnson & Johnson is far larger — about 720.8× Amphastar Pharmaceuticals Inc's market cap, and Johnson & Johnson pays a 2.06% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

AMPHJNJ
Market Cap
$868.62M$626.09B
Sector
HealthHealth
52-Week High
$30.81$267.24
52-Week Low
$16.87$172.78
Enterprise Value
$1.27B$654.37B
Volume
6,156,228
Dividend Yield
2.06%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amphastar Pharmaceuticals Inc

Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.

Read more on AMPH

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ